Top Markets
#1 QuantixAI QuantixAI +63.44%
#2 UnifAI Network UnifAI Network +35.20%
#3 DOG•GO•TO•THE•MOON (Runes) DOG•GO•TO•THE•MOON (Runes) +31.85%
#4 MowCat MowCat +31.24%
#5 GEKKO GEKKO +28.86%
#6 Prom Prom +27.97%
#7 MarsCoin MarsCoin +25.64%
#8 Kinesis Silver Kinesis Silver +24.26%
#9 Pons Pons +17.81%
#10 SuperVerse SuperVerse +17.76%
Coin of the day
QuantixAI QuantixAI
Configurações
Idioma
PORTUGUêS
Moeda
USD
Tema
Sinew Pharma Inc. Sinew Pharma Inc.

Sinew Pharma Inc.

6634
Classificação em ações #20222
Sinew Pharma Inc. is a biopharmaceutical enterprise dedicated to the research,... Sinew Pharma Inc. is a biopharmaceutical enterprise dedicated to the research, development, and commercialization of new therapeutics. Its core mission revolves around pioneering innovative solutions for hepatotoxicity-free acetaminophen and addressing various fatty liver conditions. The company's robust pipeline features SNP-610, a drug candidate currently advancing through Phase II clinical trials in Taiwan for the treatment of non-alcoholic steatohepatitis (NASH). Another early-stage compound, SNP-630, is also in preclinical development, targeting NASH. Beyond liver disease, Sinew Pharma is progressing SNP-810 for its analgesic and antipyretic properties. Furthermore, the firm is developing SNP-830 and SNP-840, positioned as liver-safe pain medications specifically for the United States market. Established in 2014, Sinew Pharma Inc. maintains its headquarters in Taipei City, Taiwan.
Preço da ação
$1.91
Valor de mercado
$136.47M
Variação (1 dia)
-1.15%
Variação (1 ano)
21.17%
País
TW
Negociar Sinew Pharma Inc. (6634)

Categoria

Healthcare
Lucros da Sinew Pharma Inc. (6634)
Lucros em 2026 TTM: 0
De acordo com os últimos relatórios financeiros da Sinew Pharma Inc., os ganhos atuais da empresa são de 0. Em 2026, a empresa teve ganhos de 0, igual a aos ganhos de 2026, que foram de 0. Os ganhos apresentados nesta página são os ganhos antes de juros e impostos, conhecidos como EBIT.
Histórico de lucros da Sinew Pharma Inc. de 2026 a 2026
Lucros no final de cada ano
Ano Lucros Alterar
Não há dados suficientes para as datas fornecidas.
Lucros de empresas semelhantes ou concorrentes
Empresa Lucros Diferença de Lucros País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
$-4.02B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US